Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now includes a new revision v3.3.2 and removes v3.2.0, reflecting a routine update to the study's version history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the government funding lapse notice from the page; this informational banner did not relate to the trial data or core content.SummaryDifference0.8%

- Check33 days agoChange DetectedA new version entry on 2024-03-27 was added to the study record history, noting updates to recruitment status and other study details; to avoid alerts for small changes, set an alert condition.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed mention of v3.1.0.SummaryDifference13%

- Check69 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.3%

- Check83 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.8%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.